GeneDx logo
Photo of Katherine Stueland

Katherine Stueland

Chief Executive Officer

Katherine Stueland is CEO of GeneDx, a health insights company. Katherine leads the GeneDx team in its mission to unlock insights from data, leading to healthier lives and a healthier society. She was appointed CEO of GeneDx in 2021 and also served as CEO of Sema4 after the two companies combined in 2022.

Katherine has more than 25 years of experience in the healthcare sector, overseeing multiple commercial organizations from start-up to scale-up and leading corporate brand transformations. Katherine’s career has been driven by her passion for how genomics can improve health outcomes and the importance of broadening research to diverse patient populations to advance science and patient care for all.

Prior to leading GeneDx, Katherine was the Chief Commercial Officer of Invitae Corporation, where she established the corporate brand as the company evolved from a private to a public entity with a market capitalization exceeding $6 billion. Before that, she served as Vice President of Communications and Investor Relations at Dendreon, the first company to bring an immuno-oncology product to market.

Katherine holds a Bachelor of Science in English Language and Literature from Miami University in Ohio.